TIDMCF. TIDMEVG
RNS Number : 4368M
Canaccord Financial Inc.
16 August 2011
CANACCORD FINANCIAL INC. DISCLOSES PRELIMINARY DISCUSSIONS WITH
EVOLUTION GROUP PLC
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN
PART, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD
CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION.
THIS IS AN ANNOUNCEMENT FALLING UNDER RULE 2.4 OF THE CITY CODE ON
TAKEOVERS AND MERGERS ("CODE"). IT DOES NOT REPRESENT A FIRM
INTENTION TO MAKE AN OFFER UNDER RULE 2.5 OF THE CODE. ACCORDINGLY,
THERE CAN BE NO CERTAINTY THAT ANY OFFER WILL BE MADE OR AS TO THE
TERMS OR TIMING OF ANY OFFER, IF MADE.
LONDON, August 16, 2011 - Canaccord Financial Inc. ("CF" or the
"Company") notes the recent press comment that CF is considering
making an approach to The Evolution Group PLC ("Evolution") . CF
confirms that it has held preliminary discussions with Evolution
regarding a potential offer for the entire issued and to be issued
share capital of Evolution.
CF's interest is subject to a number of pre-conditions
including, among others, obtaining a unanimous recommendation from
the Evolution Board and the satisfactory completion of due
diligence. CF reserves the right to waive any or all of its
pre-conditions. There can be no certainty an offer will be made,
even if the pre-conditions are satisfied or waived.
This is an announcement falling under Rule 2.4 of the City Code
on Takeovers and Mergers (the "Code"). It does not represent a firm
intention to make an offer under Rule 2.5 of the Code. Accordingly,
there can be no certainty that any offer will be made or as to the
terms or timing of any offer, if made.
A further announcement will be made as and when appropriate.
A copy of this announcement will be available subject to certain
restrictions relating to persons resident in restricted
jurisdictions at www.canaccordfinancial.com by no later than 12
noon (London time) on 17 August. The content of the website
referred to in this announcement is not incorporated into and does
not form part of this announcement.
Rule 2.10 disclosure
CF advises of the following in accordance with Rule 2.10 of the
Code: as at the close of business on August 15, 2011, it had in
issue 83,321,696 Common Shares (without par value) and 4,540,000
Series A Preferred Shares (without nominal or par value). The ISIN
for its common shares securities is CA1348011091. The ISIN for its
preferred shares is CA1348013071.
Dealing disclosure requirements of the Takeover Code (the
"Code")
Under Rule 8.3(a) of the Code, any person who is interested in
1% or more of any class of relevant securities of an offeree
company or of any paper offeror (being any offeror other than an
offeror in respect of which it has been announced that its offer
is, or is likely to be, solely in cash) must make an Opening
Position Disclosure following the commencement of the offer period
and, if later, following the announcement in which any paper
offeror is first identified. An Opening Position Disclosure must
contain details of the person's interests and short positions in,
and rights to subscribe for, any relevant securities of each of (i)
the offeree company and (ii) any paper offeror(s). An Opening
Position Disclosure by a person to whom Rule 8.3(a) applies must be
made by no later than 3:30 p.m. (London time) on the 10th business
day following the commencement of the offer period and, if
appropriate, by no later than 3:30 p.m. (London time) on the 10th
business day following the announcement in which any paper offeror
is first identified. Relevant persons who deal in the relevant
securities of the offeree company or of a paper offeror prior to
the deadline for making an Opening Position Disclosure must instead
make a Dealing Disclosure.
Under Rule 8.3(b) of the Code, any person who is, or becomes,
interested in 1% or more of any class of relevant securities of the
offeree company or of any paper offeror must make a Dealing
Disclosure if the person deals in any relevant securities of the
offeree company or of any paper offeror. A Dealing Disclosure must
contain details of the dealing concerned and of the person's
interests and short positions in, and rights to subscribe for, any
relevant securities of each of (i) the offeree company and (ii) any
paper offeror, save to the extent that these details have
previously been disclosed under Rule 8. A Dealing Disclosure by a
person to whom Rule 8.3(b) applies must be made by no later than
3:30 p.m. (London time) on the business day following the date of
the relevant dealing.
If two or more persons act together pursuant to an agreement or
understanding, whether formal or informal, to acquire or control an
interest in relevant securities of an offeree company or a paper
offeror, they will be deemed to be a single person for the purpose
of Rule 8.3.
Opening Position Disclosures must also be made by the offeree
company and by any offeror and Dealing Disclosures must also be
made by the offeree company, by any offeror and by any persons
acting in concert with any of them (see Rules 8.1, 8.2 and
8.4).
Details of the offeree and offeror companies in respect of whose
relevant securities Opening Position Disclosures and Dealing
Disclosures must be made can be found in the Disclosure Table on
the Takeover Panel's website at www.thetakeoverpanel.org.uk,
including details of the number of relevant securities in issue,
when the offer period commenced and when any offeror was first
identified. If you are in any doubt as to whether you are required
to make an Opening Position Disclosure or a Dealing Disclosure, you
should contact the Panel's Market Surveillance Unit on +44 (0) 20
7638 0129.
FOR FURTHER INFORMATION CONTACT:
North America media:
Scott Davidson
Managing Director, Global Head of Marketing &
Communications
Phone: 416-869-3875, email: scott.davidson@canaccord.com
For investor relations inquiries contact:
Jamie Kokoska Manager, Investor Relations & Communications
Phone: 416-869-3891, email: jamie.kokoska@canaccord.com
London media:
Bobby Morse or Ben Romney
Buchanan Communications (London)
Phone: +44 (0) 207 466 5000, email: bobbym@buchanan.uk.com
Nominated Adviser and Joint Broker:
Marc Milmo or Carl Holmes
Charles Stanley Securities
Phone: +44 020 7149 6764, email:
marc.milmo@csysecurities.com
Joint Broker:
Oliver Hearsey or Nick Triggs
Keefe, Bruyette & Woods Limited
Phone: +44 (0) 20 7663 5400, email: ohearsey@kbw.com
This information is provided by RNS
The company news service from the London Stock Exchange
END
OFDSFFSUMFFSELA
Grafico Azioni Evgen Pharma (LSE:EVG)
Storico
Da Giu 2024 a Lug 2024
Grafico Azioni Evgen Pharma (LSE:EVG)
Storico
Da Lug 2023 a Lug 2024